Careers  |  Sign In  |  Register  |   Twitter

FDA Approves 2-in-1 Solution for Type 2 Diabetes

The Food and Drug Administration approved a two-in-one Type-2 Diabetes pill from AstraZeneca, reports Reuters. The pill contains Xigduo XR, a combination of dapagliflozin and metformin hydrochloride, which removes glucose from the body. Xigduo XR is the first drug to combine an SGLT2 inhibitor and metformin in a single pill.

Read the article published by Reuters.